Daily Judi: Thursday, January 19, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Bloomberg Law examines the new guidance and legislation designed to increase diversity and equity in clinical trials.
Cyrano Therapeutics is developing a nasal spray to combat post-viral smell loss (hyposmia), which currently has no FDA approved therapies. Before the COVID-19 pandemic, eight million people in the United States and Europe had hyposmia, which has now increased to 40 million. Cyrano's trial is expected to enroll patients at 20 clinical sites. (Clinical Trials Arena)
DM Clinical Research opened a trial site in the Boston region and will begin recruiting for Moderna’s cytomegalovirus vaccine study. Jose Azocar, M.D., Ph.D., was named lead principal investigator at the site, and Amy Sheets will serve as regional director. DM Clinical operates 13 dedicated sites and a network of affiliates. (Fierce Biotech)
The 14th annual SCOPE Summit 2023, will take place February 6–9, 2023, in Orlando, Florida, where the clinical research community gathers to discuss continued innovation and collaboration. Team AG Mednet will be there!
Our Culture
“I work mainly with one CRO, and they thank us for being proactive, and for our precise attention. We get a lot of appreciation from their whole team as we help them with their deliverable.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
